High Potency Active Pharmaceutical Ingredient (HPAPI) Market
High Potency Active Pharmaceutical Ingredient (HPAPI) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
Press Release :
Global High Potency Active Pharmaceutical Ingredients Market – Overview
In recent years, there has been a considerable growth in the oncology research across the globe. Moreover, with the rising prevalence of variety of cancer cases, cardiovascular diseases, and diabetes among other chronic disorders, there has been a growing demand for specialized treatment methods. This growing demand has been the key driving factor for the growth of the global high potency active pharmaceutical ingredients market.
In 2014, the global high potency active pharmaceutical ingredients market stood at a valuation of US$2.64 bn. The companies in the market are adopting cost containment strategies by outsourcing their work. This is expected to help in the overall development of the global market. The additional effect this has brought in is of making a large variety of drugs that were previously expensive, in the reach of the common masses. This trend has thus helped in setting the global high potency active pharmaceutical ingredients market on the path of growth. Furthermore, the streamlining and commercialization of new drugs is also helping the overall growth of the global market. With such developments, the global market is expected to reach a new valuation of US$25.11 bn by the end of the year 2023. This growth of the market is expected to be achieved with the help of strong CAGR of 8.3% for the given forecast period of 2015 to 2023.
With increasing focus on developing highly targeted therapeutics, the high potency active pharmaceutical ingredients market is expected to achieve eye-catching growth in coming years. An important aspect here is that these new drugs have minimal or no side effects and give out better results. Thus, they help the patients to recover faster with less or no ill-effects from the treatment. Such positive impact coupled with nearing patent expiration of costlier drugs are expected to provide the much needed impetus to the global high potency active pharmaceutical ingredients market. Furthermore, increasing investments to boost the research and development activities in this field are also expected help the overall market growth.
Oncology Drug to Emerge as Most Popular HPAPI Segment
The global high potency active pharmaceutical ingredients market is segmented in terms of type of product, type of manufacturer, type of drug, and region. The drug type segment is further divided into oncology drugs, cardiovascular drugs, anti-diabetic drugs, central nervous system drugs, branded HPAPI, generic HPAPI, and musculoskeletal drugs. Of these sub segments, the oncology drugs type segment is expected to witness the highest demand. The segment is projected to exhibit a strong CAGR of 8.3% over the course of the given forecast period of 2015 to 2023. The research report expects that the patent expiry of highly popular drugs such as Humira, Rituxan, and Herceptin are expected to help the development of this segment.
China to Emerge as Leading Contributor in Growth of Asia Pacific Segment
In terms of geographical segmentation, the global high potency active pharmaceutical ingredients market is divided into five major regions viz. Latin America, Europe, Asia Pacific, Middle East and Africa, and North America. Of these, the global market is expected to be dominated by Asia Pacific region. The region is projected to present with a number of lucrative opportunities for the leading companies and is expected to exhibit a CAGR of 10.1% for the projection period of 2015 to 2023. China in particular is expected act as the chief contributor for the development of the Asia Pacific segment. China is projected to surpass the Japan’s share in the region, which is currently at 40% by the end of 2025. Factors such as low production cost, low cost of labor, and increasing drug demand are driving the development of the China market.
Some of the leading companies operating in the global high potency active pharmaceutical ingredients market include names such as Alkermes Plc., Cambrex Corporation, Dr. Reddy’s Laboratories, Lonza Group, Novasep, and Pfizer Inc. among others.
High Potency Active Pharmaceutical Ingredient Market
Rising incidence of cancer is leading to enormous amount of investment in high potency active pharmaceutical ingredient market for research and development of effective drugs. Recently, highly potent active pharmaceutical ingredient drug has been launched in the market. The developing companies claim that the drugs are capable of targeting diseased cell more precisely when compared to other drugs. The result is likely to boost demand for high highly potent active pharmaceutical ingredient drug in the coming years.
Furthermore, biotech and pharmaceutical industries are involving way more in developing such drugs. Especially, in developing economies. Aforementioned factors are anticipated to drive the high potency active pharmaceutical ingredient market in the forthcoming years.
Most of the drugs given for the treatment of cancer are cytotoxic in nature. While treating cancerous cells, the drug harms the non-cancerous cell. This incidence causes extensive damage to health of patients undergoing treatment. Hence, people tend to choose less effective drugs. However, in such case, effect is quite minimal. To overcome the concern, medical researchers are trying to bring targeted therapy approach. High potency active pharmaceutical ingredient target the cancerous cells effectively and hardly damage the healthy tissues. The factor is attributing to the wide adoption rate of high potency active pharmaceutical ingredient across the globe. This, in turn, is projected to propel growth of global high potency active pharmaceutical ingredient.
High potency active pharmaceutical ingredient are usually coupled with hormonal drugs. They are prescribed for treatment of breast cancer. Moreover, the drug is also used for treatment of glaucoma and the demand for the drug is quite high. The High potency active pharmaceutical ingredient are also found to be effective in the treatment of musculoskeletal ailments, cardiovascular diseases, and central nervous system drugs.
Growing demand for drug for treatment of various diseases are anticipated to fuel the market growth in forthcoming years.
Global high potency active pharmaceutical ingredient (HPAPI) market report provides comprehensive analysis considering various macro as well as micro economic factors. The report studies the HPAPI market from five perspectives: type of HPAPI, type of manufacturer, type of drug, therapeutic area, and geography.
The global high potency active pharmaceutical ingredient market report provides insights on contract versus captive HPAPI, synthetic versus biological HPAPI, and branded versus generic HPAPI. The global high potency active pharmaceutical ingredient market is also segmented into major therapeutic areas which include oncology, anti-diabetic, cardiovascular, central nervous system, musculoskeletal and others. From geography perspective, the market is studied for five main geographies: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America HPAPI market is sub-segmented for the U.S., Canada, while Europe HPAPI market is further segmented for Germany, U.K., and Rest of Europe. Asia Pacific HPAPI market is segmented for Japan, China and Rest of Asia Pacific. Latin America market is segmented for Brazil and Rest of Latin America. Middle East and Africa HPAPI market segmented for GCC Countries and Rest of Middle East and Africa.
Market size for each of the aforementioned segments and sub-segments is provided in US$ Mn considering 2013 and 2014 as base years and forecast from 2015 to 2023. The forecast model considers various factors such as drug patent expiry, therapeutic indication, prevalence, generic competition, anticipated drug approvals, impact of regulatory policies, industry pricing strategies and others. The research methodology is a blend of primary as well as secondary market research, where market estimates based on desk research are further refined considering inputs from expert interviews.
The global high potency active pharmaceutical ingredient market report also provides qualitative information on HPAPI manufacturing capabilities of major players in the market. The report also includes details on current regulatory policies. Major factors driving and restraining the global HPAPI market are also discussed in the report, while lucrative opportunities from future perspective are also mentioned. Furthermore, the global high potency active pharmaceutical ingredient market report also provides event impact analysis, which maps key events impacting market growth including facility expansion, mergers and acquisitions, changes in regulatory policies, drug approval, drug patent expiry and generic or biosimilars drug approval. Value chain analysis is also provided for comprehensive analysis. Porter’s five forces analysis and market share analysis of high potency active pharmaceutical ingredient market provides detailed information on current competitive landscape of the global HPAPI market. Furthermore, market attractiveness analysis provides information on most attractive geographies for HPAPI manufacturing.
Finally, the report profiles major players in the global HPAPI market which include Alkermes plc, Cambrex Corporation, Dr. Reddy's Laboratories, Lonza Group, Novasep, Sandoz International GmbH, Pfizer, Inc., Sigma-Aldrich Co. LLC., WuXi AppTec. Each of the companies are profiled for parameters including: company overview, financial overview, product portfolio, business strategies and recent developments The report represents HPAPI market estimation and forecast in the form of 26 charts and figures, and 4 tables and comprises 85 slides.